Search Count: 10
 |
Structural And Biochemical Rationale For Beta Variant Protein Booster Vaccine Broad Cross-Neutralization Of Sars-Cov-2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural And Biochemical Rationale For Beta Variant Protein Booster Vaccine Broad Cross-Neutralization Of Sars-Cov-2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Plasmodium falciparum (isolate 3d7), Plasmodium falciparum (isolate nf54)
Method: X-RAY DIFFRACTION Resolution:3.99 Å Release Date: 2020-11-11 Classification: MOTOR PROTEIN Ligands: ADP, VO4, MG |
 |
Organism: Plasmodium falciparum (isolate 3d7)
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2020-11-11 Classification: MOTOR PROTEIN Ligands: EDO, SO4, MG, ADP |
 |
Organism: Plasmodium falciparum (isolate 3d7), Plasmodium falciparum (isolate nf54)
Method: X-RAY DIFFRACTION Resolution:3.27 Å Release Date: 2020-11-11 Classification: MOTOR PROTEIN Ligands: SO4, EDO, MG, ADP |
 |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.82 Å Release Date: 2019-08-07 Classification: MOTOR PROTEIN Ligands: EDO, GOL |
 |
Organism: Plasmodium falciparum 3d7
Method: X-RAY DIFFRACTION Resolution:3.49 Å Release Date: 2019-08-07 Classification: MOTOR PROTEIN Ligands: ADP, MG, VO4 |
 |
Organism: Toxoplasma gondii (strain atcc 50611 / me49)
Method: SOLUTION NMR Release Date: 2019-01-30 Classification: LIPID BINDING PROTEIN |
 |
Organism: Plasmodium falciparum tanzania (2000708)
Method: SOLUTION NMR Release Date: 2018-12-12 Classification: LIPID BINDING PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2010-09-01 Classification: ISOMERASE Ligands: GSH, KXO, MG |